Microbiology (medical)
619 articles · 16 journals
Journals in this subcategory (16)
- Clinical Epidemiology and Global Health · Elsevier (82)
- The Lancet Microbe · Elsevier (81)
- Indian Journal of Medical Microbiology · Elsevier (80)
- Journal of Microbiological Methods · Elsevier (77)
- International Journal of Infectious Diseases · Elsevier (66)
- International Journal of Medical Microbiology · Elsevier (61)
- Enfermedades Infecciosas y Microbiología Clínica · Elsevier (44)
- Infectious Disease Clinics of North America · Elsevier (33)
- Journal of Infection · Elsevier (28)
- Revista Argentina de Microbiología · Elsevier (26)
- Infectious Medicine · Elsevier (25)
- Tuberculosis · Elsevier (16)
- Current Clinical Microbiology Reports · Springer Nature (0)
- European Journal of Clinical Microbiology & Infectious Diseases · Springer Nature (0)
- Infectious Diseases and Therapy · Springer Nature (0)
- Microbiome · Springer Nature (0)
- Mycobacterium tuberculosis complex strain discordance among people with tuberculosis and a history of household contact: a systematic review and meta-analysis
- US CDC’s 5-day recommendation of the artemether–lumefantrine regimen: lessons from Africa and travellers
- Expanding Epstein–Barr virus-associated disease burden prioritises vaccine development
- Diversity analysis of indoor and outdoor fungal bioaerosols: methodological considerations
- Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study
- Clinical and immunological correlates of CXCR4 coreceptor use in people with HIV-1 receiving antiretroviral therapy in the Netherlands: a multicentre cohort study
- Nigeria responds to Ebola Bundibugyo virus case
- No end to tuberculosis without women and children
- The silence of the alarms: Cyclospora and the fragility of foodborne surveillance
- From reactive to proactive: rethinking parasite controls in the fresh produce chain
- MERS-CoV: time to reassess the case-fatality rate
- Prevalence-adaptive sequential antigen and molecular testing for mpox at the point-of-care
- Collateral sensitivity identified in surveillance data shows limited reproducibility in clinical isolates
- Female genital schistosomiasis in migrant women: diagnostic challenges in non-endemic settings
- Visceral leishmaniasis in Brazil
- Research response to the Bundibugyo ebolavirus outbreak
- Epidemiology and phylogenomic characterisation of the 2025 Ebola virus disease outbreak in Bulape, Kasaï province, Democratic Republic of the Congo: a retrospective observational study
- Profiling the dynamics of maternally acquired and infection-induced antibodies against influenza B in early childhood: a longitudinal paired mother–infant cohort study from southern China
- Non-canonical phage–bacterium interactions during topical phage therapy in the PhagoBurn clinical trial: a retrospective, observational, reverse translational study
- A WHO International Standard for neutralising antibodies to Chikungunya virus: development and evaluation
- Genomic diversity of Trypanosoma cruzi clinical isolates: a retrospective analysis
- Genomic analysis of Echinococcus granulosus sensu stricto: genetic diversity and population structure
- Five decades of pneumococcal meningitis in Spain: a single-centre, clinical and genomic, retrospective, observational study
- Bacterial co-detection in individuals with acute respiratory infections through a direct-to-consumer platform in China: a retrospective cross-sectional study
- COVID-19 vaccine effectiveness in people on immunosuppressive therapies: a systematic review and meta-analysis
- State of the global tuberculosis epidemic: burden, progress towards WHO End TB Strategy targets and systemic challenges
- Advances in tuberculosis diagnostics and biomarkers, 2020–26: scientific evidence, recommendations, gaps, and developmental priorities
- Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines
- Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access
- mRNA vaccines for multidrug-resistant bacteria: promise, challenges, and microbiome-informed strategies